Clinical Trials Logo

Clinical Trial Summary

The Study is a single-arm prospective trial of patients receiving at least one medication with a known association between genetics and drug metabolism. All patients will undergo genetic testing as determined by their treating physician. The specific genes tested will, in general, be based upon the drugs the patients are taking or those that the patient's treating physician is considering as potential substitutes for current medications.


Clinical Trial Description

In this data collection only trial design, the PGx test is not a protocol-specified procedure. Rather, patients are eligible if they have undergone PGx testing within the last 90 days. Thus, PGx testing will not be performed solely for inclusion in this clinical research initiative. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02559193
Study type Observational [Patient Registry]
Source First Vitals LLC
Contact
Status Withdrawn
Phase
Start date January 2016
Completion date May 2018

See also
  Status Clinical Trial Phase
Recruiting NCT06018662 - An Interventional Study to Establish a Medication Management Mobile Application for Pediatric Surgery Patients N/A
Completed NCT05143047 - Discharge Medication Counseling in Hospitalized Children N/A
Completed NCT03127930 - Improving Caregiver Mediated Medication Management- The 3M Study N/A
Completed NCT01188629 - Conversational IT for Better, Safer Pediatric Primary Care Phase 2
Withdrawn NCT05711771 - Medication Therapy Management (MTM) for a Medicaid Managed Care Population Within Patient-Centered Medical Homes